Cite
MLA Citation
Paolo Prandoni et al.. “Benefits and risks of extended treatment of venous thromboembolism with rivaroxaban or with aspirin.” Thrombosis research, no. 168, 2018, pp. 121–129. http://access.bl.uk/ark:/81055/vdc_100066544130.0x000053